Cowealth Medical Holding Co Ltd
Cowealth Medical Holding Co., Ltd., together with its subsidiaries, engages in trading of medical equipment, reagents, and spare parts in Taiwan, China, and Hong Kong. It operates in two segments, Sells Equipment, and Sells Reagents and Others. The company also offers acme empowerment program, including al-assisted clinical decision support system, platform of management analysis and decision mak… Read more
Market Cap & Net Worth: Cowealth Medical Holding Co Ltd (4745)
Cowealth Medical Holding Co Ltd (TWO:4745) has a market capitalization of $45.30 Million (NT$1.50 Billion) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #24839 globally and #1525 in its home market, demonstrating a -6.07% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cowealth Medical Holding Co Ltd's stock price NT$19.35 by its total outstanding shares 77450000 (77.45 Million).
Cowealth Medical Holding Co Ltd Market Cap History: 2015 to 2026
Cowealth Medical Holding Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $72.99 Million to $45.30 Million (-4.99% CAGR).
Cowealth Medical Holding Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cowealth Medical Holding Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.01x
Cowealth Medical Holding Co Ltd's market cap is 0.01 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
76.11x
Cowealth Medical Holding Co Ltd's market cap is 76.11 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $54.11 Million | $3.04 Billion | $173.57 Million | 0.02x | 0.31x |
| 2018 | $61.67 Million | $3.90 Billion | $286.18 Million | 0.02x | 0.22x |
| 2019 | $77.13 Million | $4.67 Billion | $279.75 Million | 0.02x | 0.28x |
| 2020 | $63.58 Million | $4.72 Billion | $124.39 Million | 0.01x | 0.51x |
| 2021 | $55.63 Million | $5.14 Billion | $139.46 Million | 0.01x | 0.40x |
| 2022 | $54.97 Million | $5.63 Billion | $94.11 Million | 0.01x | 0.58x |
| 2023 | $60.39 Million | $4.81 Billion | $55.71 Million | 0.01x | 1.08x |
| 2024 | $47.87 Million | $4.19 Billion | $629.00K | 0.01x | 76.11x |
Competitor Companies of 4745 by Market Capitalization
Companies near Cowealth Medical Holding Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Cowealth Medical Holding Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Cowealth Medical Holding Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cowealth Medical Holding Co Ltd's market cap moved from $72.99 Million to $ 45.30 Million, with a yearly change of -4.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$45.30 Million | -23.67% |
| 2025 | NT$59.34 Million | +23.96% |
| 2024 | NT$47.87 Million | -20.74% |
| 2023 | NT$60.39 Million | +9.86% |
| 2022 | NT$54.97 Million | -1.19% |
| 2021 | NT$55.63 Million | -12.50% |
| 2020 | NT$63.58 Million | -17.57% |
| 2019 | NT$77.13 Million | +25.08% |
| 2018 | NT$61.67 Million | +13.96% |
| 2017 | NT$54.11 Million | -17.64% |
| 2016 | NT$65.71 Million | -9.98% |
| 2015 | NT$72.99 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cowealth Medical Holding Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $45.30 Million USD |
| MoneyControl | $45.30 Million USD |
| MarketWatch | $45.30 Million USD |
| marketcap.company | $45.30 Million USD |
| Reuters | $45.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.